Galedra

Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
In the PATHFINDER 2 study, among 32,007 performance-analyzable participants, the multi-cancer early-detection test had a 0.54% cancer detection rate, 60.3% positive predictive value, 99.2% negative predictive value, and 99.64% specificity.	QUANTITATIVE	Supported	0.9561	1 of 4	106